MONITORING PHASE

Regular evaluation of every site in each city where the study is being conducted, checking for adequate compliance with GCP in every site.
Evaluation of AE and SAE.
Close-down of the research site.
Consulting in solving queries.
Follow-up of enrolled patients to minimize drop out.
Counting of the drug received and destruction of the remaining one according to Peruvian regulations.